Principal Investigator
Lisa Domaradzki
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20221257
Clinical Trial Summary
A Phase 2, Double-Blind, Randomized, Parallel-Group,
Placebo-Controlled, Multi-Center Study to Evaluate the
Efficacy, Safety, and Tolerability of Oral Omadacycline in
Adult Subjects with Nontuberculous Mycobacterial (NTM)
Pulmonary Disease Caused by Mycobacterium abscessus
Complex (MABc)
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Pamela Barletta
Phone Number
+1 (305) 2435545
Email
pab204@miami.edu